Drug
Liposome Encapsulated Daunorubicin Cytarabine
Liposome Encapsulated Daunorubicin Cytarabine: highest development phase Phase 2, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Liposome-encapsulated Daunorubicin-Cytarabine NCT04269213 | Phase 2 | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome |
Latest
No recent events.
Follow Liposome Encapsulated Daunorubicin Cytarabine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.